Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Polymer-lipid Particle-delivered CAR1920 mRNA CAR-T Therapy for Relapsed/Refractory B-cell Lymphoma/Leukemia
ClinicalTrials.gov study NCT07321301. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Orelabrutinib Plus R-CHOP in Treatment-naïve Patients With MCD Subtype Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT05234684. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD19-targeting CAR T Cells for B Cell Lymphoma
ClinicalTrials.gov study NCT02547948. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BCOR and ZC3H12 Genes Knock-out CD19-targeting CAR-T Cell Therapy in r/r B Cell Lymphoma
ClinicalTrials.gov study NCT07009002. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prospective Clinical Study of ZPR Regimen in Elderly Treatment-naive Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT05940064. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Orelabrutinib in Combination With Gemox in Refractory / Relapsed Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT05381506. IPD Sharing: Not stated. Countries: 1. Publications: 0.
hUC Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosishepatitis b Cirrhosis
ClinicalTrials.gov study NCT03826433. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study Comparing the Efficacy and Safety of G-CHOP Versus R-CHOP in Untreated Diffuse Large B-cell Lymphoma Patients
ClinicalTrials.gov study NCT03650933. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Clinical Study of CD19 UCAR-T Cells in Patients With B-cell Acute Lymphoblastic Leukemia (B-ALL)
ClinicalTrials.gov study NCT04166838. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of TQB2303 in Patients With CD20-Positive Diffuse Large B-cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT03777085. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bortezomib in Treating Patients With Diffuse Large B-Cell Lymphoma That Is Refractory To Chemotherapy
ClinicalTrials.gov study NCT00066508. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety of Autologous Humanized Anti-CD19 and Anti-CD20 Dual Specific CAR-T Cells in Adult Patients With Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT04215016. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Assessment of Survival and Autonomy With Rituximab Plus Chemotherapy or Rituximab Plus Lenalidomide for Elderly Patients With Relapsed Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT04113226. IPD Sharing: NO. Countries: 1. Publications: 0.
Rituximab, Venetoclax, and Bortezomib for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT04285268. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With Gastric Diffuse Large B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00204659. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Novel Anti-CD19 Universal CAR-T Cells for r/r CD19+ B-ALL
ClinicalTrials.gov study NCT05639179. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD19 Targeted Chimeric Antigen Receptor T Cells for B Cell Lymphoma
ClinicalTrials.gov study NCT03118180. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
ClinicalTrials.gov study NCT06680037. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 1 Trial of BTM-3566 in Relapsed/Refractory Mature B Cell Lymphomas
ClinicalTrials.gov study NCT06792734. IPD Sharing: NO. Countries: 1. Publications: 0.
Effects of Thymoglobulin on Human B Cells
ClinicalTrials.gov study NCT02137876. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.